Primary record
(2S)-2-((4-((1RS)-1-((2, 4-Diaminopteridin-6-yl)methyl)but-3-ynyl)benzoyl)amino)pentanedioic Acid
- 库存
- 2,910 克
- 纯度
- 98.3 %
- CAS
- 146464-95-1
化合物标识与属性
- CAS
- 146464-95-1
- PubChem CID
- 148121
- SMILES
- C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O
- Canonical SMILES
- C#CCC(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1
名称与同义词
- Pralatrexate
- Folotyn
- 10-Propargyl-10-deazaaminopterin
- 146464-95-1
- pralatrexato
- pralatrexatum
- Pralatrexat
- Pralatrexte
- Folotyn (TN)
- Pralatrexate(Folotyn)
- Pralatrexate [USAN]
- DIFOLTA
- HSDB 7786
- Pralatrexate(Folotyn)/
- Pralatrexate [USAN:INN]
- RefChem:57047
- AC1L3WHA
- PRALATREXATE [MI]
- DTXSID3048578
- PRALATREXATE [INN]
- PRALATREXATE [JAN]
- CHEBI:71223
- D02LWU
- PRALATREXATE [HSDB]
- UNII-A8Q8I19Q20
- A8Q8I19Q20
- PRALATREXATE [VANDF]
- MFCD00920897
- SCHEMBL21633
- DTXCID3028504
- PRALATREXATE [MART.]
- NSC-754230
- PRALATREXATE [WHO-DD]
- OGSBUKJUDHAQEA-WMCAAGNKSA-N
- C23H23N7O5
- GTPL6840
- orb1301055
- Pralatrexate (JAN/USAN/INN)
- 146464-95-1 (racemic)
- CHEMBL1201746
- SCHEMBL15075302
- SCHEMBL29355142
- KS-00001CSH
- L01BA05
- NSC754230
- BCPP000101
- GLXC-04258
- PRALATREXATE [ORANGE BOOK]
- EX-A2142
- Tox21_112906
- (2S)-2-(4-(1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl)benzamido)pentanedioic acid
- 2667AH
- ABP000543
- BDBM50457437
- CID148121
- EBC-27202
- NCGC00242596-01
- RW3961
- s1497
- AKOS015966891
- C23-H23-N7-O5
- AM84423
- AN-6340
- CCG-269517
- CID:148121
- CS-0504
- DB06813
- NSC 754230
- QC-3214
- s11194
- 10-Propargyl-10-deazaaminopterin, 95%
- NCGC00242596-02
- NCGC00242596-05
- NCGC00386226-01
- AC-28388
- BS-15438
- DA-57020
- FP159010
- HY-10446
- SC-21536
- SID:134223179
- AB0095450
- AB2000123
- J557.257F
- L-Glutamic acid, N-[4-[1-[(2,4-diamino-6-pteridinyl)methyl]-3-butyn-1-yl]benzoyl]-
- N-(4-(1-((2,4-Diamino-6-pteridinyl)methyl)-3-butynyl)benzoyl)-L-glutamic acid
- PDX
- 2-Chloro-N-(1-cyano-cycloheptyl)-acetamide
- CAS-146464-95-1
- P2645
- ST24049028
- SW220187-1
- 10-Propargyl-10-deazaaminopterin; Pralatrexate
- D05589
- W-5219
- AB00443251-02
- AB00443251_04
- (2S)-2-((4-((1RS)-1-((2,4-Diaminopteridin-6-yl)methyl)but-3-ynyl)benzoyl)amino)pentanedioic acid
- 464P951
- A884505
- C418863
- EN300-26509071
- Q637059
- SR-01000941578
- SR-01000941578-1
- (2S)-2-[[4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl]amino]pentanedioic acid
- BRD-A74914197-001-02-9
- N-{4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl}-L-glutamic acid
- (2S)-2-({4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl}amino)pentanedioic acid
- (2S)-2-[[4-[1-[(2,4-diaminopteridin-6-yl)methyl]but-3-ynyl]benzoyl]amino]pentanedioic acid
- B0084-339953
- L-Glutamic acid, N-(4-(1-((2,4-diamino-6-pteridinyl)methyl)-3-butynyl)benzoyl)-
- N-[4-[1-[(2,4-Diamino-6-pteridinyl)methyl]-3-butyn-1-yl]benzoyl]-L-glutamic Acid
- (2S)-2-({4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]phenyl}formamido)pentanedioic acid
- N -(4-{1-[(2,4-diaminopteridin-6-yl)methyl]but-3-yn-1-yl}benzoyl)-L-glutamic acid
- (2S)-2-[[4-[(1RS)-1-[(2,4-diaminopteridin-6-yl)methyl]but-3-ynyl]benzoyl]amino]pentanedioic acid
- (4-(1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl)benzoyl)-L-glutamic acid
- (2S)-2-((4-(1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl)benzoyl)amino)pentanedioic acid
- N-(4-(1-((2,4-Diaminopteridin-6-yl)methyl)but-3-yn-1-yl)benzoyl)-L-glutamic Acid
- N-(4-(1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl)benzoyl)-L-glutamic acid
- N-[4-[1-[(2,4-Diamino-6-pteridinyl)methyl]-3-butynyl]benzoyl]-L-glutamic Acid
- N-[4-[1-[(2,4-Diaminopteridin-6-yl)methyl]-3-butynyl]benzoyl]-L-glutamic acid
- (2S)-2-((4-((1RS)-1-((2, 4-Diaminopteridin-6-yl)methyl)but-3-ynyl)benzoyl)amino)pentanedioic Acid